MiMedx Group (MDXG) is the lead sponsor of 2 active clinical trials listed on ClinicalTrials.gov[1].
MDXG has 5 Form 4 insider filings recorded at the SEC in the past 30 days[2].
MDXG is tracked by BiotechSigns with a current catalyst score of 37/100 and grade D. The page summarizes 0 active signals, including 0 PDUFA, 0 insider buying, and 0 clinical trial signals, with data refreshed on 2026-06-03.
MiMedx Group (MDXG) is the lead sponsor of 2 active clinical trials listed on ClinicalTrials.gov[1].
MDXG has 5 Form 4 insider filings recorded at the SEC in the past 30 days[2].